RE:630 x SARS-CoV-2 tests commercially available
and SONAs will be the only point of care least expensive lateral flow rapid antigen test with golden rod nanorods for high levels on specificity and reliability with tracing available in a few weeks time....60million shares outstanding..MIR had a nice run but Sonas will be unbelievable.